Citigroup
LGND icon

Citigroup’s Ligand Pharmaceuticals LGND Stock Holding History

Citigroup’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-20,038
Closed -$1.24M – 6906
2020
Q4 		$1.24M Buy
20,038
+15,389
+331% +$877K ﹤0.01% 3323
2020
Q3 		$276K Sell
4,649
-7,854
-63% -$536K ﹤0.01% 4355
2020
Q2 		$872K Sell
12,503
-2,726
-18% -$173K ﹤0.01% 3698
2020
Q1 		$691K Sell
15,229
-10,579
-41% -$600K ﹤0.01% 3557
2019
Q4 		$1.68M Buy
25,808
+3,366
+15% +$225K ﹤0.01% 3189
2019
Q3 		$1.39M Buy
22,442
+19,396
+637% +$1.22M ﹤0.01% 3273
2019
Q2 		$217K Sell
3,046
-5,771
-65% -$425K ﹤0.01% 5188
2019
Q1 		$691K Sell
8,817
-4,167
-32% -$316K ﹤0.01% 3818
2018
Q4 		$1.1M Buy
12,984
+9,938
+326% +$1.06M ﹤0.01% 3298
2018
Q3 		$522K Sell
3,046
-5,290
-63% -$798K ﹤0.01% 4229
2018
Q2 		$1.08M Sell
8,336
-10,259
-55% -$1.14M ﹤0.01% 3283
2018
Q1 		$1.92M Buy
18,595
+13,946
+300% +$1.38M ﹤0.01% 2632
2017
Q4 		$397K Buy
4,649
+3,206
+222% +$278K ﹤0.01% 4341
2017
Q3 		$123K Sell
1,443
-44,563
-97% -$3.53M ﹤0.01% 5401
2017
Q2 		$3.48M Buy
46,006
+44,884
+4,000% +$3.14M ﹤0.01% 2030
2017
Q1 		$74K Sell
1,122
-21,801
-95% -$1.43M ﹤0.01% 5430
2016
Q4 		$1.45M Buy
22,923
+18,595
+430% +$1.17M ﹤0.01% 3297
2016
Q3 		$276K Buy
+4,328
New +$318K ﹤0.01% 4408

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup's LGND Position: Q2 2026 in Review

Citigroup increased its Ligand Pharmaceuticals (LGND) stake by 209% in Q2 2026, buying an estimated $10.6M and bringing the position to 66,639 shares worth $21.1M. The position accounts for 0.01% of the portfolio, ranked #1145.

Citigroup first reported a position in LGND in Q2 2013 and has held it in 53 quarters since. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Citigroup held 66,639 shares of Ligand Pharmaceuticals worth $21.1M as of Q2 2026.
  • Citigroup bought 45,045 Ligand Pharmaceuticals shares in Q2 2026, an estimated $10.6M.
  • Ligand Pharmaceuticals made up 0.01% of Citigroup's portfolio in Q2 2026, its #1145 holding.
  • Citigroup first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.